Stock listing

Stockholm:XINT Xintela AB Aktie

Home listing (Stockholm) of Xintela AB

Follow Xintela AB into a list and get an email when it puts out news.

Share price · OMXSTO:XINT

0.163 SEK -0.001 (-0.6%)

Close on Oct 15, 2026

Ticker: Stockholm:XINT
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: Stockholm
Currency: SEK

What changed lately

Latest news release · Aug 28, 2026
Interim Report January – June 2026

Latest news

Interim Report January – June 2026

Aug 28, 2026

Xintela AB Interim Report January - June 2026

Aug 28, 2026

Xintela publishes safety and efficacy results from knee osteoarthritis clinical study with XSTEM in scientific journal

Aug 11, 2026

Xintela AB Interim Report January - March 2026

May 29, 2026

Xintela AB changes Certified Adviser to Västra Hamnen Corporate Finance AB

May 28, 2026

Xintela granted patent in Japan for XSTEM® treatment of acute respiratory distress syndrome (ARDS)

May 12, 2026

Xintela AB publishes Annual Report 2025

Apr 30, 2026

Xintela granted US patent for XSTEM treatment of difficult-to-heal wounds and skin defects

Apr 14, 2026

Xintela AB Year-end Report 2025

Feb 27, 2026

Xintela completes clinical study with XSTEM in difficult-to-heal leg ulcers

Feb 13, 2026

All Xintela AB news

Xintela AB on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 13 in the last 12 months · 15 in all · newest Aug 28, 2026 · oldest 2025

Where Xintela AB is listed

Listing	Exchange	Country	Currency
Stockholm:XINT · Home listing · This page	Stockholm	Sweden	SEK
Frankfurt:1XT	Frankfurt	Germany	EUR

Log in to ask 6ix AI your own questions about Xintela AB.